Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue Doppler imaging in patients with myocardial infarction

Clinical Physiology and Functional Imaging

Volumn 27, Issue 1, 2007, Pages 60-66

  Henareh, Loghman ^a   Lind, Britta ^a   Brodin, Lars Åke ^a   Agewall, Stefan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes mellitus; Left ventricular function; Myocardial infarction; Myocardial performance index; Tissue Doppler imaging

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDIABETIC STATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33845592821     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2007.00717.x     Document Type: Article

References (46)

1. Abd El Rahman MY, Hui W, Dsebissowa F, Hui W, Dsebissowa F, Schubert S, Hubler M, Hetzer R, Lange PE, Abdul-Khaliq H. Comparison of the tissue Doppler-derived left ventricular Tei index to that obtained by pulse Doppler in patients with congenital and acquired heart disease. Pediatr Cardiol (2005); 26: 391-395.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998); 15: 539-553.
3. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol (2000); 36: 959-969.
4. American Heart Association. 2002 Heart and Stroke Statistical Update (2003). American Heart Association, Dallas, TX.
5. Bach DS, Armstrong WF, Donovan CL, Muller DW. Quantitative Doppler tissue imaging for assessment of regional myocardial velocities during transient ischemia and reperfusion. Am Heart J (1996); 132: 721-725.
6. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes (1991); 40: 405-412.
7. Bell DS. Heart failure: The frequent, forgotten, and often fatal complication of diabetes. Diabetes Care (2003); 26: 2433-2441.
8. Brodin LA. Tissue Doppler, a fundamental tool for parametric imaging. Clin Physiol Funct Imaging (2004); 24: 147-155.
9. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes (1994); 43: 836-841.
10. Bruch C, Schmermund A, Marin D, Katz M, Bartel T, Schaar J, Erbel R. Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J (2000); 21: 1888-1895.
11. Chatterjee K. Congestive heart failure: What should be the initial therapy and why? Am J Cardiovasc Drugs (2002); 2: 1-6.
12. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol (2003); 42: 328-335.
13. Eidem BW, Tei C, O'Leary PW, Cetta F, Seward JB. Nongeometric quantitative assessment of right and left ventricular function: myocardial performance index in normal children and patients with Ebstein anomaly. J Am Soc Echocardiogr (1998); 11: 849-856.
14. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warnet JM, Claude JR, Rosselin GE. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia (1989); 32: 300-304.
15. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) (1983); 287: 867-870.
16. Gaballa MLB, Storaa C, van der linden J, Brodin L-Å. Intra-and interobsever reproducibility in off-line extracted cardiac tissue Doppler velocity measurement and drived variables. Prec IEEE. Eng Med Biol (2001); 1: 4-6.
17. Gaibazzi N, Petrucci N, Ziacchi V. Left ventricle myocardial performance index derived either by conventional method or mitral annulus tissue-Doppler: A comparison study in healthy subjects and subjects with heart failure. J Am Soc Echocardiogr (2005); 18: 1270-1276.
18. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC. Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study. J Am Coll Cardiol (2000); 35: 1628-1637.
19. Govind S, Saha S, Brodin LA, Ramesh SS, Arvind SR, Quintana M. Impaired myocardial functional reserve in hypertension and diabetes mellitus without coronary artery disease: Searching for the possible link with congestive heart failure in the myocardial Doppler in diabetes (MYDID) study II. Am J Hypertens (2006); 19: 851-857, discussion 858.
20. Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: DiabeEes and Cardiovascular Disease: executive summary: Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2002); 105: 2231-2239.
21. Harada K, Tamura M, Toyono M, Yasuoka K. Comparison of the right ventricular Tei index by tissue Doppler imaging to that obtained by pulsed Doppler in children without heart disease. Am J Cardiol (2002); 90: 566-569.
22. Henareh L, Berglund M, Agewall S. Should oral glucose tolerance test be a routine examination after a myocardial infarction? Int J Cardiol (2004); 97: 21-24.
23. HOPE study and MICRO-HOPE-substudy. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet (2000); 355: 253-259.
24. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV. Glycemic control and heart failure among adult patients with diabetes. Circulation (2001); 103: 2668-2673.
25. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL. Importance of heart failure with preserved systolic function in patients > or = 65years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001); 87: 413-419.
26. Kuikka JT, Mustonen JN, Uusitupa MI, Rautio P, Vanninen E, Laakso M, Lansimies E, Pyorala K. Demonstration of disturbed free fatty acid metabolism of myocardium in patients with non-insulin-dependent diabetes mellitus as measured with iodine-123-heptadecanoic acid. Eur J Nucl Med (1991); 18: 475-481.
27. Lavine SJ. Effect of heart rate and preload on index of myocardial performance in the normal and abnormal left ventricle. J Am Soc Echocardiogr (2005); 18: 133-141.
28. Lax JA, Bermann AM, Cianciulli TF, Morita LA, Masoli O, Prezioso HA. Estimation of the ejection fraction in patients with myocardial infarction obtained from the combined index of systolic and diastolic left ventricular function: A new method. J Am Soc Echocardiogr (2000); 13: 116-123.
29. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care (1997); 20: 163-169.
30. Lyons TJ. Lipoprotein glycation and its metabolic consequences. Diabetes (1992); 41 (Suppl. 2): 67-73.
31. Marwick TH, Case C, Sawada S, Vasey C, Short L, Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care (2002); 25: 1042-1048.
32. Miyatake K, Yamagishi M, Tanaka N, Uematsu M, Yamazaki N, Mine Y, Sano A, Hirama M. New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging: In vitro and in vivo studies. J Am Coll Cardiol (1995); 25: 717-724.
33. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: An update. Diabetes Care (2004); 27: 1879-1884.
34. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care (2001); 24: 5-10.
35. Poulsen SH, Nielsen JC, Andersen HR. The influence of heart rate on the Doppler-derived myocardial performance index. J Am Soc Echocardiogr (2000); 13: 379-384.
36. Riggs TW, Transue D. Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol (1990); 65: 899-902.
37. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol (1972); 30: 595-602.
38. Severino S, Caso P, Galderisi M, De Simone L, Petrocelli A, de Divitiis O, Mininni N. Use of pulsed Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy. Am J Cardiol (1998); 82: 1394-1398.
39. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes (1992); 41: 202-208.
40. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol (1989); 14: 49-57.
41. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB. New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol (1995); 26: 357-366.
42. Tekten T, Onbasili AO, Ceyhan C, Unal S, Discigil B. Novel approach to measure myocardial performance index: Pulsed-wave tissue Doppler echocardiography. Echocardiography (2003); 20: 503-510.
43. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999); 33: 1948-1955.
44. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest (1994); 70: 138-151.
45. Zarich SW, Arbuckle BE, Cohen LR, Roberts M, Nesto RW. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol (1988); 12: 114-120.
46. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci U S A (2000); 97: 1784-1789.